Articles with "pathway inhibition" as a keyword



Photo by myriamzilles from unsplash

MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Cellular Biochemistry"

DOI: 10.1002/jcb.27451

Abstract: Unraveling molecular mechanisms that regulate tumor development and proliferation is of the utmost importance in the quest to decrease the high mortality rate of adrenocortical carcinomas (ACC). Our aim was to evaluate the role of… read more here.

Keywords: pathway inhibition; treatment; mapk; erk pathway ... See more keywords
Photo from wikipedia

Probing the multimodal fungiform papilla: complex peripheral nerve endings of chorda tympani taste and mechanosensitive fibers before and after Hedgehog pathway inhibition

Sign Up to like & get
recommendations!
Published in 2021 at "Cell and Tissue Research"

DOI: 10.1007/s00441-021-03561-1

Abstract: The fungiform papilla (FP) is a gustatory and somatosensory structure incorporating chorda tympani (CT) nerve fibers that innervate taste buds (TB) and also contain somatosensory endings for touch and temperature. Hedgehog (HH) pathway inhibition eliminates… read more here.

Keywords: pathway inhibition; fungiform papilla; inhibition; chorda tympani ... See more keywords
Photo by tcwillmott from unsplash

Anti-inflammatory effects of an optimized PPAR-γ agonist via NF-κB pathway inhibition.

Sign Up to like & get
recommendations!
Published in 2020 at "Bioorganic chemistry"

DOI: 10.1016/j.bioorg.2020.103611

Abstract: In our previous study, a PPAR-γ agonist (+)-(R,E)-6a1 was elaborated as an anti-inflammatory lead. However, in silico analysis showed that (+)-(R,E)-6a1 lacks key hydrogen bonding with Tyr473 of PPAR-γ LBD (ligand binding domain). To facilitate… read more here.

Keywords: anti inflammatory; pathway inhibition; inhibition; via pathway ... See more keywords
Photo from archive.org

Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition.

Sign Up to like & get
recommendations!
Published in 2019 at "Thrombosis research"

DOI: 10.1016/j.thromres.2019.09.033

Abstract: This review provides the rationale for dual pathway inhibition with the combination of low-dose rivaroxaban (2.5 mg twice daily) to attenuate thrombin generation and aspirin (100 mg once daily) to reduce platelet activation. Such therapy has been… read more here.

Keywords: rivaroxaban plus; pathway inhibition; dual pathway;
Photo by tcwillmott from unsplash

State-of-the-art-mini review: Dual pathway inhibition to reduce arterial and venous thromboembolism.

Sign Up to like & get
recommendations!
Published in 2022 at "Thrombosis and haemostasis"

DOI: 10.1055/a-1778-1083

Abstract: Venous thromboembolism (VTE) and arterial thromboembolism (ATE) are linked by the common mechanism of thrombin generation. Historically these entities have been treated as separate pathophysiologic processes requiring different treatments: VTE, as the formation of fibrin-/coagulation-factor-derived… read more here.

Keywords: pathway inhibition; dual pathway; thromboembolism; venous thromboembolism ... See more keywords
Photo from wikipedia

Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence.

Sign Up to like & get
recommendations!
Published in 2020 at "Thrombosis and haemostasis"

DOI: 10.1055/s-0040-1713376

Abstract: Despite advances in secondary prevention strategies in patients with cardiovascular disease, the residual risk of recurrent atherothrombotic events remains high. Dual-antiplatelet therapy is the standard of care for secondary prevention in patients with acute coronary… read more here.

Keywords: pathway inhibition; patients atherosclerotic; atherosclerotic disease; vascular protection ... See more keywords
Photo from wikipedia

Dual Pathway Inhibition with Rivaroxaban and Aspirin Reduces Inflammatory Biomarkers in Atherosclerosis

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Cardiovascular Pharmacology"

DOI: 10.1097/fjc.0000000000001382

Abstract: Abstract: Dual pathway inhibition (DPI) with low-dose rivaroxaban and aspirin in patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD) reduces the occurrence of cardiovascular (CV) events; however, the underlying mechanisms explaining these… read more here.

Keywords: pathway inhibition; pathway; dual pathway; rivaroxaban aspirin ... See more keywords
Photo from wikipedia

Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs

Sign Up to like & get
recommendations!
Published in 2023 at "Journal for Immunotherapy of Cancer"

DOI: 10.1136/jitc-2022-006555

Abstract: With multiple PD-(L)1 inhibitors approved across dozens of indications by the US Food and Drug Administration, the number of patients exposed to these agents in adjuvant, first-line metastatic, second-line metastatic, and refractory treatment settings is… read more here.

Keywords: addressing resistance; inhibition considerations; trial; resistance ... See more keywords
Photo by tcwillmott from unsplash

SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma

Sign Up to like & get
recommendations!
Published in 2019 at "Endocrine-Related Cancer"

DOI: 10.1530/erc-18-0538

Abstract: Pharmacological inhibition of the sonic hedgehog (SHH) pathway can be beneficial against certain cancers but detrimental in others. Adamantinomatous craniopharyngioma (ACP) is a relevant pituitary tumour, affecting children and adults, that is associated with high… read more here.

Keywords: shh pathway; pathway inhibition; shh; adamantinomatous craniopharyngioma ... See more keywords
Photo from wikipedia

FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?

Sign Up to like & get
recommendations!
Published in 2022 at "Life"

DOI: 10.3390/life12010081

Abstract: Gastric cancer (GC) is the third leading cause of cancer-associated death worldwide. The majority of patients are diagnosed at an advanced/metastatic stage of disease due to a lack of specific symptoms and lack of screening… read more here.

Keywords: fgfr pathway; inhibition gastric; gastric cancer; pathway inhibition ... See more keywords
Photo from wikipedia

Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells

Sign Up to like & get
recommendations!
Published in 2022 at "Molecules"

DOI: 10.3390/molecules27196709

Abstract: In this study, a series of coumarin derivatives, either alone or as hybrids with cinnamic acid, were synthesized and evaluated for their cytotoxicity against a panel of cancer cells using the MTT assay. Then, the… read more here.

Keywords: pi3k akt; coumarin derivatives; cytotoxic agents; pathway inhibition ... See more keywords